Laura Rozenblum

13PUBLICATIONS
26CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Gene and molecular therapyMedical infection agents (incl. prions)Peripheral nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 13, 2026
18 F-DOPA PET Silence in High-grade Glioma Subtype F : A Distinct Metabolic Phenotype.

Chloé Quéré, Franck Bielle, Alberto Picca

|Feb 02, 2026
18F-DOPA-PET and Advanced MRI Improve Treatment Response Assessment in IDH1/2-Mutant Gliomas Treated with IDH Inhibitors.

Diego Prost, Lucia Nichelli, Laura Rozenblum

|Nov 12, 2025
18F-FDG versus 18F-FDOPA PET in recurrent medulloblastoma: a case study and literature review.

Abarnaa Sivapathasundaram, Florence Laigle-Donadey, Catherine Horodyckid

|Jun 28, 2025
Longitudinal PET and MRI Evaluation in Late Onset Rasmussen Encephalitis: A Series of Three Cases.

Laura Rozenblum, Lydia Chougar, Franck Bielle

|Dec 18, 2024
Cognitive Impairment and Brain Metabolic Changes in Post-Acute Sequelae of COVID-19: Insights From an [ 18 F]FDG PET/CT Cohort Study.

Laura Rozenblum, Thomas Debroucker, Marie-Odile Habert

|Feb 17, 2024
Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric study.

Laura Rozenblum, Caroline Houillier, Amandine Baptiste

Pageof 3

Frequent Collaborators

3 joint publications

Bertrand Mathon

2 joint publications

Laurent Dercle

2 joint publications

Alice Laurenge

1 joint publications

Marc Bertaux